TITLE

Is Neoadjuvant Hormonal Therapy before Radical Prostatectomy Indicated?

AUTHOR(S)
Chun, Judy; Pruthi, Ray S.
PUB. DATE
May 2004
SOURCE
Urologia Internationalis;May2004, Vol. 72 Issue 4, p275
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: Despite the success of surgical monotherapy in treating patients with organ-confined disease, nearly half of all patients undergoing radical prostatectomy will be pathologically upstaged on evaluation of the operative specimen. One possible means of improving the proportion of patients with organ-confined disease and cancer-negative margins at surgery is implementing neoadjuvant androgen deprivation therapy. Studies evaluating the use of neoadjuvant hormonal therapy (NHT) before radical prostatectomy will be reviewed, and outcomes will be discussed. Methods: Review of the past and recent literature regarding the use and role of NHT before radical prostatectomy was performed. In particular, special attention was paid to the seven prospective, randomized studies that have been reported in the literature. In addition, review of other pertinent and appropriate texts and journals regarding the impact of hormonal therapy on histopathological evaluation and outcomes was performed. Results: Upon review of the prospective, randomized, clinical trials of NHT before radical prostatectomy, there remains no clear evidence that NHT improves disease-free survival for any stage of prostate cancer. Although positive surgical margins appear to be reduced for patients with clinical stage T2 disease only, significance and validity of such an end point remain uncertain. In addition, the use of NHT appears to come with a significant cost with regard to financial expense, patient morbidity, and possibly increased surgical difficulty. Conclusions: The routine use of NHT before radical prostatectomy is not justified, and only in controlled investigational trials should its use be considered. Copyright © 2004 S. Karger AG, Basel
ACCESSION #
13216954

 

Related Articles

  • Androgen deprivation therapies prolong QT interval. Bankhead, Charles // Urology Times;Sep2004, Vol. 32 Issue 13, p22 

    Reports on the effect of hormonal therapies that induce androgen deprivation on the electrocardiographic QT interval according to a data from three trials of hormone therapy for prostate cancer. Statement of Marc Garnick, chief officer at Praecis Pharmaceuticals on the clinical study; Basis of...

  • Expression of X-linked inhibitor of apoptosis protein in human prostate cancer specimens with and without neo-adjuvant hormonal therapy. Watanabe, Shin-ichi; Miyata, Yasuyoshi; Kanda, Shigeru; Iwata, Takahisa; Hayashi, Tomayoshi; Kanetake, Hiroshi; Sakai, Hideki // Journal of Cancer Research & Clinical Oncology;May2010, Vol. 136 Issue 5, p787 

    X-linked inhibitor of apoptosis (XIAP) has high affinity and strong inhibitory activity on apoptosis-related caspase-3. The relationships between expression of XIAP and cleaved caspase-3, and response to neo-adjuvant hormonal therapy (NHT) remain elusive. The aim was to investigate whether NHT...

  • Neoadjuvant Hormonal Therapy in Radical Prostatectomy and Radiation-Treated Patients. Schmid; Semjonow; Aus; Hertle // Urologia Internationalis;Aug2000, Vol. 65 Issue 2, p63 

    Presents a study on the administration of neoadjuvant hormonal therapy in radical prostatectomy and radiation-treated patients. Principles of neoadjuvant therapy; Diagnosis of prostate carcinoma; Efficiency of the radical prostatectomy technique.

  • Enhancing the Efficacy of Radical Prostatectomy in Locally Advanced Prostate Cancer. Altwein // Urologia Internationalis;1998 Supplement 2, Vol. 60, p2 

    Locally advanced prostate cancer patients comprise those with iatrogenic capsular injury, extracapsular extension resulting in positive surgical margins following radical prostatectomy, and tumors with lymph node metastases, thus representing stage T3,N0,M0 or T1–4,N1–2,M0 disease....

  • Positive resection margins may not reflect the true margin in patients undergoing radical prostatectomy. NOBUKI FURUBAYASHI; TAKAHITO NEGISHI; YU HIRATA; KENICHI TAGUCHI; MOTOTSUGU SHIMOKAWA; MOTONOBU NAKAMURA // Oncology Letters;2014, Vol. 8 Issue 5, p2237 

    The aim of the present study was to evaluate the hypothesis that a positive resection margin (RM1) of an excised specimen may not reflect the true margin in patients that have undergone radical prostatectomy (RP). Between September 2003 and March 2011, 370 Japanese patients underwent an...

  • Flow-related techniques for preoperative goal-directed fluid optimization. M. Bundgaard-Nielsen; B. Ruhnau; N. H. Secher; H. Kehlet // BJA: The British Journal of Anaesthesia;Jan2007, Vol. 98 Issue 1, p38 

    Background. Improved postoperative outcome has been demonstrated by perioperative maximization of cardiac stroke volume (SV) with fluid challenges, so-called goal-directed therapy. Oesophageal Doppler (OD) has been the most common technique for goal-directed therapy, but other flow-related...

  • Intermittent suppression as effective as continuous. Mulcahy, Nicholas // Urology Times;Sep2004, Vol. 32 Issue 13, p21 

    Reports on the data presented on the equivalent effect of intermittent androgen suppression with continuous androgen deprivation in patients with a prostate specific antigen (PSA) relapse after radical prostatectomy at the AUA annual meeting. Views of Ulf Tunn, director of the Urology Clinic,...

  • Prostate Cancer's Difficult Choices. Springen, Karen; Adler, Jerry // Newsweek (Atlantic Edition);6/16/2003 (Atlantic Edition), Vol. 141 Issue 24, p36 

    Discusses treatment options for prostate cancer. Function of the prostate; Cancer that is the second most common form of cancer in men; Deaths from prostate cancer that are declining; Decrease that is a tribute to better diagnosis and treatment; Development of a simple test for prostate...

  • Prostate Cancer's Difficult Choices. Springen, Karen; Adler, Jerry // Newsweek (Pacific Edition);6/16/2003 (Pacific Edition), Vol. 141 Issue 24, p26 

    Discusses treatment options for prostate cancer. Function of the prostate; Cancer that is the second most common form of cancer in men; Deaths from prostate cancer that are declining; Decrease that is a tribute to better diagnosis and treatment; Development of a simple test for prostate...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics